|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.125 SEK | +1.63% |
|
-3.85% | -47.48% |
| 05-13 | Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Bio Vitos Pharma AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 0.134308 million compared to SEK 0.525555 million a year ago. Net loss was SEK 3.15 million compared to SEK 3.15 million a year ago.
Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -47.48% | 3.49M | |
| -11.68% | 11.22B | |
| +27.58% | 5.48B | |
| +1.44% | 5.38B | |
| -17.38% | 3.77B | |
| +8.12% | 2.6B | |
| -64.90% | 2.35B | |
| -10.17% | 2.25B | |
| +26.75% | 2.2B | |
| -12.53% | 1.7B |
BIO VITOS PHARMA AB 
